Safety first.., well done on the ptx100 trial.
Efficacy next.., 2 from 5 (TCL cohort), partial response (40%).
Durability of TCL cohort.., 12-17 month’s survival rate compared to the baseline of approximately 4 months.
Market reaction was certainly mixed (imo).
Either the results were hypothetically already factored in or many reacted emotionally (imo).
Hopefully the briefing will add some light to the results.
Either way, a follow-up cohort is next.
Ann: PTX-100 trial advances following successful Phase 1b, page-118
-
- There are more pages in this discussion • 289 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $30.60M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 3.9¢ | 3.8¢ | $47.91K | 1.256M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 881755 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 150000 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PTX (ASX) Chart |